CIRB-20-0026
A081801-Alchemist Sub-Study: This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery.
Locations: Corbin, Lexington, Louisville, Madisonville, Paducah
View Details